Odonate Therapeutics, Inc. — key financial figures for fiscal year 2020 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2020)

-$126.3M

Total Assets (FY2020)

$167.9M

Total Equity (FY2020)

$136.1M

Cash Flows from Operating Activities (FY2020)

-$113.1M

Source: Odonate Therapeutics, Inc. 10-K filing (FY2020). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.